Hold 2% core C; no additions into multi-tested $141.14 resistance with deteriorating volume — wait for breakout ≥10M or pullback to $132-134
Maintain the 2% core C position initiated 8/11 at $135-136. Do NOT add at current $137.65 into multi-tested $141.14 resistance — declining volume (5.5M on 8/18 vs 12-15M YTD average) is the textbook distribution signature, not absorption. The discipline to wait for confirmation has generated alpha on 8/10, 8/13, and 8/17. Hard stop $130; trim 25% at $147-150 ahead of Q3 2026 earnings. Position sizing ≤3% portfolio weight regardless of direction.
| Position | Action |
|---|---|
| Maximum portfolio weight regardless of direction | ≤3% total position size cap |
| Breakout trigger: close >$140.75-141.14 with volume ≥10M shares (post-50 SMA reclaim) | Add 0.5% to core position |
| Pullback trigger: price into $132-134 zone (10 EMA/lower BB convergence) | Add 0.5% to core position |
| Rally to $147-150 ahead of Q3 2026 earnings (mid-October) | Trim 25% of position to harvest gains and reduce binary event exposure |
| Close <$130 on rising volume (failed retest signaling distribution) | Exit position entirely |
| Q3 ROE <9% normalized with forward EPS revisions materially down | Exit position or significantly reduce |
| Weekly close <$118.96 (200 SMA — secular trend broken) | Exit position entirely |
Citigroup is undergoing a multi-quarter earnings inflection that the market has not yet fully priced, with Q2 2026 results demonstrating tripled EPS power, expanding NII, accelerating buybacks, and three strategic growth catalysts—all aligning at a compressed 10.68x forward P/E with technical momentum turning bullish.
| Indicator | Value | Signal |
|---|---|---|
| 200 SMA | $119.99 | bullish |
| 50 SMA | $136.70 | bullish |
| 10 EMA | $136.91 | bullish |
| MACD Line | 1.03 | bullish |
| MACD Signal | 0.40 | neutral |
| MACD Histogram | 0.63 | bullish |
| RSI | 55.14 | neutral |
| ATR | $3.13 | neutral |
| Bollinger Upper Band | $141.14 | neutral |
| Bollinger Mid Band | $134.41 | neutral |
| Bollinger Lower Band | $127.68 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed close above $140.75-141.14 with volume ≥10M shares, post-50 SMA reclaim
Then: Add 0.5% position
ROE trajectory is sharply upward, not stagnant at the 8.53% snapshot
EV: upside · concedes: Prefer a 3–5% pullback into the $134–136 zone as higher-conviction entry; Acknowledges technical entry-timing concerns that landed research package on HOLD; Volume concern on current setup is real but explainable (quiet accumulation pattern vs July capitulation)
Citigroup's Q2 2026 "inflection" is a one-quarter trading anomaly dressed up as a structural trend; the stock remains a value trap due to persistently sub-peer ROE, a dangerous 20x net debt surge, flat tangible book value, and a structural valuation discount that reflects rational market pricing of genuine franchise weaknesses, not a temporary inefficiency.
· concedes: Q2 2026 EPS of $3.15 is a real reported number; Q2 2026 annualized ROE of 12.1% is mathematically accurate from reported figures; The 8.3% share count reduction did improve per-share metrics; The $771B in cash and equivalents is a real balance sheet figure; Current price of $137.65 may offer some support near recent lows
→ vs conservative: The conservative's three-failed-attempts argument is 'recency bias masquerading as discipline'—waiting for $141.14 breakout confirmation means buying into the meat of the move and surrendering favorable risk/reward at 50 SMA with $132 stop
→ vs conservative: The $18B to $363B net debt increase is misinterpreted—Citigroup expanded total assets from $2.36T to $2.89T ($530B) through deposit gathering and securities portfolio build-out in a profitable steep curve environment, not speculative leverage
→ vs conservative: Waiting for ROE to 'prove itself' at >12% means buying after the market has already re-rated the stock—that's the game the conservative is losing by being patient
→ vs conservative: The 3% portfolio weight cap is leaving 20-30% upside on the table; position should be 4-5%
→ vs neutral: The neutral's 'unfavorable asymmetry' characterization is contradicted by Forward P/E of 10.68x and PEG of 0.75—this is asymmetric in the aggressive analyst's favor, not unfavorable
→ vs neutral: The $141.14 breakout trigger is too rigid; entry at 50 SMA support ($136.70) gives better cost basis than chasing resistance
| neutral |
Support: 136.7 · 134.41 · 132 · 127.68 | Resistance: 139.3 · 140.5 · 141.14 · 147.21
Citigroup (C) maintains a bullish long-term structure with the 200 SMA rising from $107.89 (May 2026) to $119.99, and price recovering +36% from the March 2026 low of $101.02. Short-term momentum has turned constructive with a fresh MACD bullish crossover on 2026-08-13, and both the 10 EMA ($136.91) and 50 SMA ($136.70) have been reclaimed. However, RSI at 55.14 is mid-range, the upper Bollinger band at $141.14 caps upside, and volume on the August recovery (5.5M) is well below the YTD average (12-15M), suggesting a lack of institutional conviction. ATR has compressed to $3.13 from the $4.02 July peak, allowing for normalized position sizing. Final recommendation: HOLD — prefer pullbacks to the $134-136 zone or a decisive break above $141.14 with volume expansion to establish new longs.
Market Cap
$230.9B
P/E Ratio (TTM)
14.83x
Forward P/E
10.68x
PEG Ratio
0.75
Price/Book
1.20x
EPS (TTM)
$9.28
Forward EPS
$12.88
Dividend Yield
1.93%
Beta
1.10
52-Week High
$147.96
52-Week Low
$90.68
50-Day MA
$137.12
200-Day MA
$120.88
Book Value/Share
$114.74
Revenue (TTM)
$81.7B
Net Income (TTM)
$16.46B
Revenue 2022
$74.5B
Revenue 2023
$78.1B
Revenue 2024
$80.7B
Revenue 2025
$85.2B
Net Income 2022
$14.85B
Net Income 2023
$9.23B
Net Income 2024
$12.68B
Net Income 2025
$14.31B
Diluted EPS 2022
$7.00
Diluted EPS 2023
$4.04
Diluted EPS 2024
$5.94
Diluted EPS 2025
$6.99
Net Interest Income 2022
$48.7B
Net Interest Income 2023
$54.9B
Net Interest Income 2024
$54.1B
Net Interest Income 2025
$59.8B
Net Interest Income (TTM)
~$63.5B
Revenue Q2 2025
$21.66B
Revenue Q3 2025
$22.10B
Revenue Q4 2025
$19.67B
Revenue Q1 2026
$24.66B
Revenue Q2 2026
$24.77B
Net Income Q2 2025
$4.02B
Net Income Q3 2025
$3.75B
Net Income Q4 2025
$2.47B
Net Income Q1 2026
$5.79B
Net Income Q2 2026
$5.83B
Diluted EPS Q2 2025
$1.96
Diluted EPS Q3 2025
$1.86
Diluted EPS Q4 2025
$1.19
Diluted EPS Q1 2026
$3.06
Diluted EPS Q2 2026
$3.15
Profit Margin
21.83%
Operating Margin
36.23%
Return on Equity (ROE)
8.53%
Return on Assets (ROA)
0.66%
Total Assets
$2.89T
Net Loans
$773.6B
Investments & Advances
$806.4B
Cash & Equivalents
$366.4B
Cash, Equivalents & Fed Funds Sold
$771.1B
Total Liabilities
$2.68T
Total Debt
$402.7B
Long-Term Debt
$333.7B
Current Debt
$69.0B
Common Equity
$192.5B
Preferred Equity
$19.6B
Total Stockholders Equity
$212.0B
Tangible Book Value
$168.4B
Net Tangible Assets
$188.0B
Net Debt
$363.1B
Common Equity Ratio
6.65%
Preferred / Total Equity
9.2%
Invested Capital
$595.2B
Total Capitalization
$545.8B
Operating CF Q2 2025
-$36.58B
Operating CF Q3 2025
$1.10B
Operating CF Q4 2025
$26.56B
Operating CF Q1 2026
-$21.87B
Operating CF Q2 2026
-$24.08B
Investing CF Q2 2025
$50.03B
Investing CF Q3 2025
-$10.00B
Investing CF Q4 2025
-$49.33B
Investing CF Q1 2026
-$12.39B
Investing CF Q2 2026
-$106.22B
Financing CF Q2 2025
$7.09B
Financing CF Q3 2025
$20.69B
Financing CF Q4 2025
$25.28B
Financing CF Q1 2026
$71.25B
Financing CF Q2 2026
$110.91B
Net Change in Cash Q2 2025
$20.54B
Net Change in Cash Q3 2025
$11.78B
Net Change in Cash Q4 2025
$2.51B
Net Change in Cash Q1 2026
$36.99B
Net Change in Cash Q2 2026
-$19.39B
FCF Q2 2025
-$38.33B
FCF Q3 2025
-$0.52B
FCF Q4 2025
$24.92B
FCF Q1 2026
-$23.29B
FCF Q2 2026
-$25.63B
CapEx (Q2 2026)
$1.55B
Interest Paid
~$20B
Buybacks (Q2 2025)
$4.0B
Buybacks (Q3 2025)
$5.0B
Buybacks (Q4 2025)
$4.5B
Buybacks (Q1 2026)
$6.3B
Buybacks (Q2 2026)
$8.6B
Buybacks (TTM)
~$23.5B
Dividends Paid
~$1.35B
Dividends Paid (TTM)
~$5.4B
Diluted Shares Outstanding
1.736B
Diluted Shares Outstanding (Start)
1.893B
Treasury Stock
$99.4B
Interest Income Q2 2026
$37.66B
Interest Expense Q2 2026
$20.54B
Net Interest Income Q2 2026
$17.13B
SG&A Q2 2026
$8.29B
Effective Tax Rate Q2 2026
25.0%
Strengths
Concerns
Citigroup is in a fundamental inflection with Q2 2026 delivering the strongest quarterly EPS in the dataset at $3.15, representing a 165% jump from Q4 2025's trough of $1.19. Revenue has expanded to $24.77B per quarter in 2026 from the $21-22B range in 2025, driven by net interest margin expansion (NII +12.9% YoY) and improving operating leverage. The stock appears undervalued with a forward P/E of 10.68x versus implied ~38% EPS growth and a PEG ratio of 0.75, trading at a discount to peer banks. Capital return acceleration is notable with buybacks ramping from $4.0B to $8.6B per quarter, reducing diluted shares by 8.3% in just 5 quarters. Key risks include aggressive balance sheet expansion ($2.89T assets, +$240B in 6 quarters), a sharp surge in net debt to $363.1B from $18.1B, and ROE/ROA metrics that remain below peer benchmarks. The setup is favorable for investors with a 12-24 month horizon if balance sheet growth is prudently funded.
Macro: Fed pricing flipped hawkish: 85% probability of no rate cuts in 2026, though hike probabilities are falling (50% any hike, down 9pp week-over-week; 28% by September, down 13pp; 38% by October, down 11pp). Inflation cooling: 8% probability of >5% inflation in 2026 (down 4.5pp), 12% for >4.5% (down 8pp). U.S. recession odds at 8% (−1pp week-over-week). 30-year Treasury at 19-year high with steep yield curve preserved — positive for bank NII but signals potential credit/fiscal concerns. Recession odds: U.S. 8%, UK 12%, Japan 31%.